You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CARBINOXAMINE MALEATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Carbinoxamine Maleate patents expire, and when can generic versions of Carbinoxamine Maleate launch?

Carbinoxamine Maleate is a drug marketed by Cypress Pharm, Endo Operations, Genus, Invagen Pharms, Mikart, Mission Pharmacal, and Strides Pharma. and is included in nine NDAs.

The generic ingredient in CARBINOXAMINE MALEATE is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carbinoxamine Maleate

A generic version of CARBINOXAMINE MALEATE was approved as carbinoxamine maleate by GENUS on March 19th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CARBINOXAMINE MALEATE?
  • What are the global sales for CARBINOXAMINE MALEATE?
  • What is Average Wholesale Price for CARBINOXAMINE MALEATE?
Drug patent expirations by year for CARBINOXAMINE MALEATE
Drug Prices for CARBINOXAMINE MALEATE

See drug prices for CARBINOXAMINE MALEATE

Pharmacology for CARBINOXAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for CARBINOXAMINE MALEATE

US Patents and Regulatory Information for CARBINOXAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 090418-001 May 4, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 207484-001 May 31, 2016 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090417-001 Aug 23, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.